Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression

Cancer immunology research

Volumn 1, Issue 4, 2013, Pages 245-255

  Oda, Shannon K ^a   Strauch, Pamela ^a   Fujiwara, Yuko ^a   Al Shami, Amin ^a   Oravecz, Tamas ^a   Tigyi, Gabor ^a   Pelanda, Roberta ^a   Torres, Raul M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CD8 T cells; GPR92; LPA5; Lysophosphatidic acid; melanoma

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID;

ANIMAL; C57BL MOUSE; CARCINOGENESIS; CD8+ T LYMPHOCYTE; DRUG EFFECTS; IMMUNOLOGY; IMMUNOSURVEILLANCE; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MELANOMA; METABOLISM; MOUSE; ONCOGENESIS AND MALIGNANT TRANSFORMATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CARCINOGENESIS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; IMMUNOLOGIC SURVEILLANCE; LYMPHOCYTE ACTIVATION; LYSOPHOSPHOLIPIDS; MELANOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASTIC PROCESSES; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 85006320570     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0043-T     Document Type: Article

References (0)